SB 437, a bill passed Wednesday by the Arkansas House by a vote of 60-31, introduces a number of new issues to the debate on whether or not pseudoephedrine and similar ingredients should be sold behind the counter or by prescription only.
The Arkansas House on Wednesday passed a bill that would restrict the behind-the-counter sale of pseudoephedrine to pharmacists only. In other words, pharmacy technicians no longer would be allowed to sell products containing PSE.